Author:
Beer Ellen,Chowdhury Humayra,Carroll Bernadette,Luintel Akish,van Tulleken Christoffer,Longley Nicky
Abstract
Abstract
Background
Immunocompromised travellers (ICTs) face greater infectious and non-infectious travel-associated risks than their immunocompetent counterparts. Increasing travel and emergence of novel immunosuppressants poses great challenges for travel medicine practitioners to confidently provide up-to-date evidence-based risk management advice and pre-travel care for ICTs.
Methods
We reviewed the records of ICTs attending the London Hospital for Tropical Diseases (HTD) Travel Clinic between 1st April 2019 and 30th April 2020 with the aim to describe demographic and travel characteristics, type, and severity of immunocompromise, the degree of risk associated with intended travel and evaluate travel advice.
Results
Of the 193 ICTs identified, immunocompromise was due to physiological reasons (42%), chronic infection (17.1%) and immunosuppressive therapy (16.6%). Median age was 38 (range 9 months to 84 years) and male to female ratio 0.75 (83:110). Travel was intended to 80 countries for a median of 16 days (range 2 to 3167), predominantly for leisure (53%), non-medical work (17%) and visiting friends and relatives (12%). Live vaccine safety dominated discussion in the pre-travel consultation. Existing guidelines arguably fell short in dealing with travel risks associated with hyper-specific conditions, targeted immunosuppressants and non-vaccine preventable infections.
Conclusions
Our cohort represents a wide spectrum of immunocompromise, for whom we arguably need more measurable ways to approach travel-associated risks. We propose prospective qualitative participatory research to inform our unit of the priorities of ICTs in the pre-travel consultation. We further recommend the formation of a repository of specialists and formulary of complex cases to direct subsequent informative systematic review and prospective risk studies.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Office for National Statistics. Travel Trends 2021 2021 [Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/leisureandtourism/articles/traveltrends/2021
2. Wieten RW, Leenstra T, Goorhuis A, van Vugt M, Grobusch MP. Health risks of travelers with medical conditions–a retrospective analysis. J Travel Med. 2012;19(2):104–10.
3. van Aalst M, van Ruissen MCE, Verhoeven R, de Bree GJ, Goorhuis A, Grobusch MP. Travel-related health problems in the immunocompromised traveller: an exploratory study. Travel Med Infect Dis. 2018;25:50–7.
4. Dekkiche S, de Vallière S, D’Acremont V, Genton B. Travel-related health risks in moderately and severely immunocompromised patients: a case-control study. J Travel Med. 2016;23(3).
5. Ericsson CD. Travellers with pre-existing medical conditions. Int J Antimicrob Agents. 2003;21(2):181–8.